Directory
>
Sandra Nino-Siddens Pharmd
Sandra Nino-Siddens Pharmd
Vice President Global Regulatory Affairs | Ultragenyx
San Francisco, California, United States
Sandra Nino-Siddens Pharmd
Summary
Sandra Nino-Siddens is a seasoned executive in Global Regulatory Affairs with over 20 years of experience in drug development, specializing in oncology, ophthalmology, and rare diseases. She has a proven track record of successfully navigating the complexities of regulatory submissions and compliance across a variety of therapeutic areas. Sandra's expertise encompasses all stages of drug development, from pre-clinical to post-approval, making her a valuable asset in the pharmaceutical industry. She has held leadership roles at prestigious companies such as Ultragenyx and Genentech, where she has led significant regulatory initiatives. Sandra is passionate about innovation and change management within the biopharmaceutical sector. Her educational background includes a Pharm.D. and a Master's in International Drug Development and Registration from Université Paris Sud. She is dedicated to advancing healthcare solutions and improving patient outcomes through effective regulatory strategies.
Sandra Nino-Siddens Pharmd
Work Experience
Vice President Global Regulatory Affairs at
Ultragenyx
April 2022 - Present
Senior Group Director and Global Regulatory Lead Ophthalmology at
Genentech Foundation
March 2020 - Present
Group Director, Regulatory Affairs Oncology at
Genentech Foundation
March 2013 - Present
Head of Clinical Regulatory Affairs at
Geron Corporation
August 2011 - January 2013
Head of Regulatory Affairs Americas at
Icon Clothing Company
March 2007 - August 2011
Head of Regulatory Affairs (Hana Biosciences) at
Spectrum Pharmaceuticals, Inc.
June 2005 - January 2007
Regulatory Affairs at
Genentech Foundation
February 2003 - June 2005
Global Regulatory Affairs at
Pfizer, Inc.
January 1998 - February 2003
Sandra Nino-Siddens Pharmd
Education
Université Paris Sud (Paris XI), Pharm.D.
January 1992 - January 1998
PharmD
Université Paris Sud (Paris XI), Master In International Drug Development And Registration
Frequently Asked Questions about Sandra Nino-Siddens Pharmd
What is Sandra Nino-Siddens Pharmd email address?
Sandra Nino-Siddens Pharmd's primary email address is ******************@gene.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Sandra Nino-Siddens Pharmd work for?
Sandra Nino-Siddens Pharmd is a Vice President Global Regulatory Affairs at Ultragenyx, a company specializing in Offices of Physicians.
Where Sandra Nino-Siddens Pharmd graduated from?
Sandra Nino-Siddens Pharmd holds a degree in Pharmacy from Université Paris Sud (Paris XI).
How can I directly contact Sandra Nino-Siddens Pharmd?
To contact Sandra Nino-Siddens Pharmd directly, you can use the email address ******************@gene.com. Complete contact information is available upon registration with Muraena.
Is Sandra Nino-Siddens Pharmd an immigrant?
Yes, Sandra Nino-Siddens Pharmd is an immigrant and currently based in United States
Who is Sandra Nino-Siddens Pharmd?
Sandra Nino-Siddens is a seasoned executive in Global Regulatory Affairs with over 20 years of experience in drug development, specializing in oncology, ophthalmology, and rare diseases. She has a proven track record of successfully navigating the complexities of regulatory submissions and compliance across a variety of therapeutic areas. Sandra's expertise encompasses all stages of drug development, from pre-clinical to post-approval, making her a valuable asset in the pharmaceutical industry. She has held leadership roles at prestigious companies such as Ultragenyx and Genentech, where she has led significant regulatory initiatives. Sandra is passionate about innovation and change management within the biopharmaceutical sector. Her educational background includes a Pharm.D. and a Master's in International Drug Development and Registration from Université Paris Sud. She is dedicated to advancing healthcare solutions and improving patient outcomes through effective regulatory strategies.
Sandra`s contact details
******************@gene.com
*******************@genentech.com
********@ultragenyx.com
Colleagues
Vice President, Market Access Channel Operations & Patient Engagement
Vice President, Quality Assurance
SVP, Intellectual Property
Vice President Procurement
Chief Accounting Officer (CAO), SVP
SVP and Head of Global Medical
SVP, Data Sciences & Development Strategy
Executive Director & Head of Global Safety Science, DSPV
Executive Director, Global Engineering & Capital Projects
SVP Regulatory Affairs